Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Gastroenterology Clinics of North America|December 20, 2002
Decision making in gastroesophageal reflux disease. What are the critical issues?Joshua J Ofman
The American Journal of Gastroenterology|March 20, 2003
The economic and quality-of-life impact of symptomatic gastroesophageal reflux diseaseJoshua J Ofman
The American Journal of Gastroenterology|August 23, 2002
Gastroesophageal reflux disease--should we adopt a new conceptual framework?Ronnie Fass, Joshua J Ofman
The American Journal of Managed Care|January 4, 2021
Novel multicancer early detection technology-potential value to employers and the workforceJoshua J Ofman, A Mark Fendrick, Azra Raza
Arthritis and Rheumatism|April 9, 2005
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groupsBrennan M R Spiegel, Chiun-Fang Chiou, Joshua J Ofman
Alimentary Pharmacology & Therapeutics|February 28, 2002
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux diseaseJoshua J Ofman, G H Dorn, M B Fennerty, et al.
The American Journal of Medicine|June 5, 2004
Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysisJoshua J Ofman, Enkhe Badamgarav, James M Henning, et al.
The American Journal of Gastroenterology|January 16, 2003
Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategiesBrennan M R Spiegel, Joshua J Ofman, Karen Woods, et al.
The American Journal of Gastroenterology|October 3, 2002
Suspected inflammatory bowel disease--the clinical and economic impact of competing diagnostic strategiesMarla C Dubinsky, John F Johanson, Ernest G Seidman, et al.
Pageof 4